PEPTONIC Medical AB

Peptonic Medical is a pharmaceutical company. Currently, the focus is on the treatment of female vaginal atrophy. The company offers a treatment free from oestrogen, where the products contain the oxytocin hormone. A large part of the projects is carried out in collaboration with other industry players. The main business is found on the Nordic market. The company is based in Bromma.

Quotes for PEPTONIC Medical AB

Right Now

+/-
%
Latest
High
Low
Volume
Turnover ()
Time (Latest trade)

Board

CEO

  • Anna Linton

Chairperson of the Board

  • Anders Blom

Board

  • Daniel Rudeklint
  • Jacob Eriksson
  • Tarek Schoeb
  • Articles of association

    • News

    Show More

    News agencies

    Show More

    Analysis

    Videos

    Peptonic Medical - Småbolagsdagen Stockholm 3 juni 2019

    VD Johan Inborr intervjuas hos Aktiespararna

    Analysguiden - Intervju med Johan Inborr

    Johan Inborr presenterar Peptonic på Småbolagsdagen

    Largest Owners

    Name Capital % Votes % Date
    Maida Vale Capital AB 31,56 31,56 2025-06-26
    Nordnet Pensionsförsäkring 5,12 5,12 2025-06-26
    Heli Kurjanen 3,71 3,71 2023-12-31
    Henrik Hahn 2,68 2,68 2025-06-26
    Petter Eriksson 2,29 2,29 2025-06-26
    Avanza Pension 1,98 1,98 2025-06-26
    Mika Kurjanen 1,93 1,93 2023-12-31
    Quartier Latin AB 1,90 1,90 2025-06-26
    Vidarstiftelsen 1,82 1,82 2025-06-26
    Joachim Lindell 0,84 0,84 2025-06-26
    ** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

    Insider trading

    *Source: Holdings by Modular Finance AB. Compiled and processed data from the Swedish Financial Supervisory Authority

    Key Numbers

    *Compiled data from Millistream

    Upcoming reports

    • 2025-11-06 Delårsrapport 2025-Q3

    • 2026-02-25 Bokslutskommuniké 2025

    Annual reports, prospectus etc.